Literature DB >> 21307981

Genetic susceptibility to autoimmune liver disease.

Jochen Mattner1.   

Abstract

Autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC) are considered as putative autoimmune diseases of the liver. Whereas strong evidence that bacterial infection may trigger PBC exists, the etiologies for PSC and AIH remain unknown. Although there have been significant discoveries of genetic polymorphisms that may underlie the susceptibility to these liver diseases, their associations with environmental triggers and the subsequent implications have been difficult to elucidate. While single nucleotide polymorphisms within the negative costimulatory molecule cytotoxic T lymphocyte antigen 4 (CTLA-4) have been suggested as genetic susceptibility factors for all three disorders, we discuss the implications of CTLA-4 susceptibility alleles mainly in the context of PBC, where Novosphingobium aromaticivorans, an ubiquitous alphaproteobacterium, has recently been specifically associated with the pathogenesis of this devastating liver disease. Ultimately, the discovery of infectious triggers of PBC may expand the concept of genetic susceptibility in immune-mediated liver diseases from the concept of aberrant immune responses against self-antigens to insufficient and/or inappropriate immunological defense mechanisms allowing microbes to cross natural barriers, establish infection and damage respective target organs.

Entities:  

Keywords:  Diabetes; Natural killer T cells, Cytotoxic T lymphocyte antigen 4; Non-obese diabetic congenic mice; Novosphingobium; Primary biliary cirrhosis; Susceptibility loci

Year:  2011        PMID: 21307981      PMCID: PMC3035697          DOI: 10.4254/wjh.v3.i1.1

Source DB:  PubMed          Journal:  World J Hepatol


  66 in total

1.  A native soluble form of CTLA-4.

Authors:  M K Oaks; K M Hallett; R T Penwell; E C Stauber; S J Warren; A J Tector
Journal:  Cell Immunol       Date:  2000-05-01       Impact factor: 4.868

Review 2.  Liver: An organ with predominant innate immunity.

Authors:  Bin Gao; Won-Il Jeong; Zhigang Tian
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

3.  Increased susceptibility to Strongyloides venezuelensis in mice due to Mycobacterium bovis co-infection which modulates production of Th2 cytokines.

Authors:  A M Carmo; M A Vicentini; A T Dias; L L Alves; C C S Alves; J S Brandi; M L De Paula; A Fernandes; M M Barsante; M A Souza; H C Teixeira; D Negrão-Corrêa; A P Ferreira
Journal:  Parasitology       Date:  2009-08-07       Impact factor: 3.234

4.  Proposal of Sphingomonadaceae fam. nov., consisting of Sphingomonas Yabuuchi et al. 1990, Erythrobacter Shiba and Shimidu 1982, Erythromicrobium Yurkov et al. 1994, Porphyrobacter Fuerst et al. 1993, Zymomonas Kluyver and van Niel 1936, and Sandaracinobacter Yurkov et al. 1997, with the type genus Sphingomonas Yabuuchi et al. 1990.

Authors:  Y Kosako; E Yabuuchi; T Naka; N Fujiwara; K Kobayashi
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

5.  Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection.

Authors:  John J Zaunders; Susanna Ip; Mee Ling Munier; Daniel E Kaufmann; Kazuo Suzuki; Choechoe Brereton; Sarah C Sasson; Nabila Seddiki; Kersten Koelsch; Alan Landay; Pat Grey; Robert Finlayson; John Kaldor; Eric S Rosenberg; Bruce D Walker; Barbara Fazekas de St Groth; David A Cooper; Anthony D Kelleher
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

Authors:  Gideon M Hirschfield; Xiangdong Liu; Chun Xu; Yue Lu; Gang Xie; Yan Lu; Xiangjun Gu; Erin J Walker; Kaiyan Jing; Brian D Juran; Andrew L Mason; Robert P Myers; Kevork M Peltekian; Cameron N Ghent; Catalina Coltescu; Elizabeth J Atkinson; E Jenny Heathcote; Konstantinos N Lazaridis; Christopher I Amos; Katherine A Siminovitch
Journal:  N Engl J Med       Date:  2009-05-20       Impact factor: 91.245

7.  Modulation of tryptophan catabolism by regulatory T cells.

Authors:  Francesca Fallarino; Ursula Grohmann; Kwang Woo Hwang; Ciriana Orabona; Carmine Vacca; Roberta Bianchi; Maria Laura Belladonna; Maria Cristina Fioretti; Maria-Luisa Alegre; Paolo Puccetti
Journal:  Nat Immunol       Date:  2003-10-26       Impact factor: 25.606

8.  The genetic basis of primary biliary cirrhosis: premises, not promises.

Authors:  Pietro Invernizzi; M Eric Gershwin
Journal:  Gastroenterology       Date:  2008-09-04       Impact factor: 22.682

9.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

10.  CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms.

Authors:  Wataru Ise; Masako Kohyama; Katherine M Nutsch; Hyang Mi Lee; Anish Suri; Emil R Unanue; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2009-12-27       Impact factor: 25.606

View more
  3 in total

1.  Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.

Authors:  Leila Ksiaa Cheikhrouhou; Yousr Lakhoua-Gorgi; Imen Sfar; Salwa Jendoubi-Ayed; Houda Aouadi; Mouna Makhlouf; Khaled Ayed; Taieb Ben Abdallah
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

2.  Inhibition of autoimmune Chagas-like heart disease by bone marrow transplantation.

Authors:  Maria C Guimaro; Rozeneide M Alves; Ester Rose; Alessandro O Sousa; Ana de Cássia Rosa; Mariana M Hecht; Marcelo V Sousa; Rafael R Andrade; Tamires Vital; Jiří Plachy; Nadjar Nitz; Jiří Hejnar; Clever C Gomes; Antonio R L Teixeira
Journal:  PLoS Negl Trop Dis       Date:  2014-12-18

Review 3.  Stem cell therapies for autoimmune hepatitis.

Authors:  Ahmed Lotfy; Aya Elgamal; Anna Burdzinska; Ayman A Swelum; Reham Soliman; Ayman A Hassan; Gamal Shiha
Journal:  Stem Cell Res Ther       Date:  2021-07-07       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.